Freedom of information request on isolation document of covid-19 and ingredients of pfizer vaccine (foi 20-576)

* Medicines & Healthcare products Regulatory Agency FOI release FREEDOM OF INFORMATION REQUEST ON ISOLATION DOCUMENT OF COVID-19 AND INGREDIENTS OF PFIZER VACCINE (FOI 20-576) Published

24 March 2021 © Crown copyright 2021 This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit

nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: [email protected].

Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned. This publication is available at

https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-4-january-2021/freedom-of-information-request-on-isolation-document-of-covid-19-and-ingredients-of-pfizer-vaccine-foi-20-576

Thank you for your email. The list of ingredients in the Pfizer/BioNTech vaccine is available in the Information for healthcare professionals and the Information for UK recipients of the

vaccine, see links below:

https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/940565/Information_for_Healthcare_Professionals_on_Pfizer_BioNTech_COVID-19_vaccine.pdf

https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/940566/Information_for_UK_recipients_on_Pfizer_BioNTech_COVID-19_vaccine.pdf Information

concerning the isolation of the Covid-19 virus is available as part of the Scientific Advisory Group for Emergencies (SAGE) website, a link to the website is provided below:

https://www.gov.uk/government/organisations/scientific-advisory-group-for-emergencies Regarding approved swine flu vaccines, two vaccines were approved for the H1N1 virus by the European

Medicines Agency (EMA) in 2009, further details (including the composition of each vaccine) are provided below:

https://www.ema.europa.eu/en/news/european-medicines-agency-recommends-authorisation-two-vaccines-influenza-pandemic-h1n1-2009 Regarding any damages paid out by the UK government following

administration of either swine flu vaccine, the MHRA holds no information on this. With regards to both vaccines for H1N1, Focetria and Pandemrix, documents published on the EMA website

state that both products were discontinued because of a lack of demand. If you are dissatisfied with the handling of your request, you have the right to ask for an internal review. Internal

review requests should be submitted within two months of the date you receive this response and addressed to: [email protected] . Please remember to quote the reference number above in any

future communications. Please note, due to the ongoing Covid-19 situation, we are not able to accept delivery of any documents or correspondence by post or courier to any of our offices. If

you were to remain dissatisfied with the outcome of the internal review, you would have the right to apply directly to the Information Commissioner for a decision. Please bear in mind that

the Information Commissioner will not normally review our handling of your request unless you have first contacted us to conduct an internal review. The Information Commissioner can be

contacted at: Information Commissioner’s Office Wycliffe House Water Lane Wilmslow Cheshire SK9 5AF Yours sincerely, MHRA Customer Service Centre Medicines and Healthcare products Regulatory

Agency 10 South Colonnade, Canary Wharf, London E14 4PU Telephone 020 3080 6000 Back to top